Reliability of Panel-Based Mutational Signatures for Immune-Checkpoint-inhibition Efficacy Prediction in Non-Small Cell Lung Cancer.
Lung cancer(2023)
Key words
Immunotherapy,Mutational signatures,Non -small cell lung cancer,Panel sequencing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined